"If you ve possibly been exposed to the coronavirus (COVID-19) and are experiencing symptoms, we recommend that your first contact with a health care provider be through telemedicine. Houston Methodist Virtual Urgent Care is available 24/7- no appointment necessary. Or, if you re planning an in-person visit, please call ahead to inform your healthcare provider."

During the past decade, Houston Methodist West Hospital conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 2 clinical trials were completed, i.e. on average, 13.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 2 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Houston Methodist West Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 8 trials, followed by "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "Canadian Cancer Trials Group" with 1 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored and "NRG Oncology" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Houston Methodist West Hospital" #1 collaborator was "NRG Oncology" with 5 trials as a collaborator, "National Cancer Institute (NCI)" with 5 trials as a collaborator, "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Canadian Cancer Trials Group" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Houston Methodist West Hospital" are "Invasive Breast Carcinoma" (2 trials), "Lung Non-Squamous Non-Small Cell Carcinoma" (2 trials), "Ovarian Seromucinous Carcinoma" (2 trials), "Recurrent Fallopian Tube Clear Cell Adenocarcinoma" (2 trials) and "Recurrent Fallopian Tube Endometrioid Adenocarcinoma" (2 trials). Many other conditions were trialed in "Houston Methodist West Hospital" in a lesser frequency.

Most popular intervention types in "Houston Methodist West Hospital" are "Other" (12 trials), "Drug" (11 trials), "Biological" (8 trials), "Procedure" (7 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (7 trials), "Biospecimen Collection" (6 trials), "Questionnaire Administration" (6 trials), "Computed Tomography" (5 trials) and "Pembrolizumab" (5 trials). Other intervention names were less common.

The vast majority of trials in "Houston Methodist West Hospital" are 10 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Houston Methodist West Hospital". undefined are not yet recruiting, 8 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Houston Methodist West Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Houston Methodist West Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".